Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll New promising drug targets in cancer- and metastasis-initiating cells Mimeault M; Batra SKDrug Discov Today 2010[May]; 15 (9-10): 354-64The unique properties of cancer- and metastasis-initiating cells endowed with a high self-renewal and aberrant differentiation potential (including their elevated expression levels of anti-apoptotic factors, multidrug transporters, and DNA repair and detoxifying enzymes) might be associated with their resistance to current clinical cancer therapies and disease recurrence. The eradication of cancer- and metastasis-initiating cells by molecular targeting of distinct deregulated signaling elements that might contribute to their sustained growth, survival, and treatment resistance, therefore, is of immense therapeutic interest. These novel targeted approaches should improve the efficacy of current therapeutic treatments against highly aggressive, metastatic, recurrent, and lethal cancers.|Animals[MESH]|Antineoplastic Agents/*administration & dosage/*pharmacology[MESH]|Drug Delivery Systems/*methods[MESH]|Drug Resistance, Neoplasm[MESH]|Drug Screening Assays, Antitumor/methods[MESH]|Drugs, Investigational/*administration & dosage/*pharmacology[MESH]|Humans[MESH]|Models, Biological[MESH]|Neoplasm Metastasis/*prevention & control[MESH]|Signal Transduction/drug effects[MESH] |